Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1

Yangyang Ou(Wuhan University), Xiaoli Li(Fujian Medical University), Nan Wu(Indiana University School of Medicine), Deng-Gao Zhai(Central South University)
Cited by 44


Related Papers